AZN
Price
$75.48
Change
+$0.31 (+0.41%)
Updated
Apr 29, 6:59 PM EST
86 days until earnings call
JNJ
Price
$146.84
Change
+$0.71 (+0.49%)
Updated
Apr 29, 6:59 PM EST
77 days until earnings call
Ad is loading...

Analysis and predictions AZN vs JNJ

Header iconAZN vs JNJ Comparison
Open Charts AZN vs JNJBanner chart's image
AstraZeneca
Price$75.48
Change+$0.31 (+0.41%)
Volume$1.99M
CapitalizationN/A
Johnson & Johnson
Price$146.84
Change+$0.71 (+0.49%)
Volume$2.13M
CapitalizationN/A
View a ticker or compare two or three
AZN vs JNJ Comparison Chart

Loading...

AZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AZN vs. JNJ commentary
Apr 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Buy and JNJ is a Hold.

COMPARISON
Comparison
Apr 30, 2024
Stock price -- (AZN: $75.17 vs. JNJ: $146.14)
Brand notoriety: AZN and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 123% vs. JNJ: 83%
Market capitalization -- AZN: $208.98B vs. JNJ: $380.22B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, both AZN and JNJ are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 5 bullish, 4 bearish.
  • JNJ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZN is a better buy in the short-term than JNJ.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +9.66% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -1.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.41%. For the same industry, the average monthly price growth was -4.83%, and the average quarterly price growth was +1.05%.

Reported Earning Dates

AZN is expected to report earnings on Jul 25, 2024.

JNJ is expected to report earnings on Jul 16, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.41% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AZN with price predictions.
OPEN
A.I.dvisor published
a Summary for JNJ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than AZN($209B). AZN has higher P/E ratio than JNJ: AZN (35.30) vs JNJ (30.34). AZN YTD gains are higher at: 13.326 vs. JNJ (-6.055). JNJ has higher annual earnings (EBITDA): 23.3B vs. AZN (13.4B). JNJ has more cash in the bank: 22.9B vs. AZN (5.86B). AZN (28.6B) and JNJ (29.3B) have identical debt. JNJ has higher revenues than AZN: JNJ (85.2B) vs AZN (45.8B).
AZNJNJAZN / JNJ
Capitalization209B380B55%
EBITDA13.4B23.3B58%
Gain YTD13.326-6.055-220%
P/E Ratio35.3030.34116%
Revenue45.8B85.2B54%
Total Cash5.86B22.9B26%
Total Debt28.6B29.3B98%
FUNDAMENTALS RATINGS
AZN vs JNJ: Fundamental Ratings
AZN
JNJ
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
839
SMR RATING
1..100
5720
PRICE GROWTH RATING
1..100
4461
P/E GROWTH RATING
1..100
8089
SEASONALITY SCORE
1..100
n/a40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (13) in the Pharmaceuticals Major industry is in the same range as AZN (22). This means that JNJ’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (8) in the Pharmaceuticals Major industry is in the same range as JNJ (39). This means that AZN’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's SMR Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for AZN (57). This means that JNJ’s stock grew somewhat faster than AZN’s over the last 12 months.

AZN's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as JNJ (61). This means that AZN’s stock grew similarly to JNJ’s over the last 12 months.

AZN's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as JNJ (89). This means that AZN’s stock grew similarly to JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNJNJ
RSI
ODDS (%)
Bearish Trend 4 days ago
46%
Bullish Trend 4 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
50%
Bullish Trend 4 days ago
55%
Momentum
ODDS (%)
Bullish Trend 4 days ago
59%
Bearish Trend 4 days ago
42%
MACD
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 4 days ago
41%
Advances
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 7 days ago
43%
Declines
ODDS (%)
Bearish Trend 14 days ago
44%
Bearish Trend 4 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
49%
Bullish Trend 4 days ago
51%
Aroon
ODDS (%)
Bullish Trend 4 days ago
49%
Bearish Trend 4 days ago
39%
View a ticker or compare two or three
Ad is loading...
AZNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JNJDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWH3.330.05
+1.42%
Aspira Women's Health
AVT50.100.52
+1.05%
Avnet
TRP36.100.01
+0.03%
TC Energy Corp
DM0.82N/A
-0.29%
Desktop Metal
HCI115.00-1.08
-0.93%
HCI Group